基于 3 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Explore the detailed record of transactions filed by Rapp Michael, 董事. Officer active across 2 companies, notably Immunome Inc.. Aggregated, 6 reports have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €1m. Activity tracked since 24 May 2021. The latest transaction was filed on 2 October 2023 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Michael Rapp is a Board Member at Immunome Inc. In this role, he contributes to overseeing the company's activities and making strategic decisions. Rapp brings his expertise in corporate governance and biotechnology, which is essential for guiding the organization's direction. His commitment to innovation and research is an asset to the board.